Patents by Inventor John Shine

John Shine has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6917760
    Abstract: A method and apparatus is provided for reformatting or interleaving a WDM signal that includes a plurality of optical channels having a first bandwidth and a first channel spacing. The method begins by receiving the WDM signal and dividing it into first and second subsets of optical channels each having a second channel spacing. Next, the first subset of optical channels are divided into third and fourth subsets of optical channels each having a third channel spacing. In addition, the second subset of optical channels is divided into fifth and sixth subsets of optical channels each having a fourth channel spacing. The third and fifth subsets of optical channels are combined to generate a first output WDM signal, while the fourth and sixth subsets of optical channels are combined to generate a second output WDM signal.
    Type: Grant
    Filed: December 31, 2001
    Date of Patent: July 12, 2005
    Assignee: Wavesplitter Technologies, Inc.
    Inventors: Yuan P. Li, Yan Wang, Robert John Shine, Jr., Kevin Sullivan
  • Patent number: 6597449
    Abstract: A system and method for real time process control, using a linearly swept tunable laser, which allows high speed in-situ monitoring and control of wavelength-specific properties of optical components. The invention comprises scanning an optical component with a high speed, high linearity tunable laser, and detecting optical output from the component during the scanning. Preferably, the invention also includes adjusting or controlling the optical properties of the component during scanning, according to detected optical output from the component. The invention is embodied in a process control system comprising a high speed, high linearity, tunable operatively coupled to an optical component which in turn is operatively coupled to an optical detector. A system control processor is operatively coupled to the tunable laser and detector. A processing control unit is associated with the optical component and is operatively coupled to the system control processor.
    Type: Grant
    Filed: January 31, 2000
    Date of Patent: July 22, 2003
    Assignee: New Focus, Inc.
    Inventors: Gregory L. Smolka, Mark Wippich, Carter F. Hand, Robert John Shine, Jr.
  • Publication number: 20030123878
    Abstract: A method and apparatus is provided for reformatting or interleaving a WDM signal that includes a plurality of optical channels having a first bandwidth and a first channel spacing. The method begins by receiving the WDM signal and dividing it into first and second subsets of optical channels each having a second channel spacing. Next, the first subset of optical channels are divided into third and fourth subsets of optical channels each having a third channel spacing. In addition, the second subset of optical channels is divided into fifth and sixth subsets of optical channels each having a fourth channel spacing. The third and fifth subsets of optical channels are combined to generate a first output WDM signal, while the fourth and sixth subsets of optical channels are combined to generate a second output WDM signal.
    Type: Application
    Filed: December 31, 2001
    Publication date: July 3, 2003
    Inventors: Yuan P. Li, Yan Wang, Robert John Shine, Kevin Sullivan
  • Patent number: 5756460
    Abstract: The present invention provides a peptide having the amino acid sequence of human galanin. The amino acid sequence of this peptide is: GWTLNSAGYLLGPHAVGNHRSFSDKNGLTS (SEQ ID NO: 1). The present invention further provides DNA clones encoding the peptide and to therapeutic uses of the peptide.
    Type: Grant
    Filed: July 25, 1995
    Date of Patent: May 26, 1998
    Assignee: Garvan Institute of Medical Research
    Inventors: Helen Frances Evans, John Shine
  • Patent number: 5571695
    Abstract: The invention provides cDNA sequence and a genomic DNA sequence which encodes the human neuropeptide Y-Y1 receptor. These DNA sequences can be used to express the NPY-Y1 receptor in cells and can be sued to screen compounds for neuropeptide Y agonist and antagonist activity.
    Type: Grant
    Filed: May 26, 1994
    Date of Patent: November 5, 1996
    Assignee: Garvan Institute of Medical Research
    Inventors: Lisa Selbie, Herbert Herzog, John Shine
  • Patent number: 5320953
    Abstract: Genes and DNA transfer vector for the expression of human prepororelaxin; subunits thereof, including genes and transfer vectors for expression of human profelaxin and the individual A, B and C peptide chains thereof; and equivalents of al such genes. Methods for synthesis of the peptides involving recombinant DNA techniques.
    Type: Grant
    Filed: July 29, 1992
    Date of Patent: June 14, 1994
    Assignee: Howard Florey Institute of Experimental Physiology and Medicine
    Inventors: Peter J. Hudson, John Shine, Hugh D. Niall, Geoffrey W. Tregear
  • Patent number: 5145962
    Abstract: Genes and DNA transfer vector for the expression of human preprorelaxin; subunits thereof, including genes and transfer vectors for expression of human prorelaxin and the individual A, B and C peptide chains thereof; and equivalents of all such genes. Methods for synthesis of the peptides involving recombinant DNA techniques.
    Type: Grant
    Filed: April 8, 1991
    Date of Patent: September 8, 1992
    Assignee: Howard Florey Institute of Experimental Physiology and Medicine
    Inventors: Peter J. Hudson, John Shine, Hugh D. Niall, Geoffrey W. Tregear
  • Patent number: 5137816
    Abstract: This invention provides useful promoters from the R. trifolii nifH gene for the construction of recombinant molecules to regulate foreign genes for expression under desired conditions. In particular, the promoters act to control expression of the foreign genes within root nodules formed by rhizobial bacterial strains in symbiotic combination with host plants.A rhizobium diagnostic segment (RDS) is also provided comprising a DNA segment found at more than one location in rhizobia, the RDS being species-specific, and detectable by DNA hybridization under stringent conditions. A recombinant plasmid comprising a RDS and a bacterial strain containing the plasmid are provided. Methods are provided for identifying species and strains of field isolates of Rhizobium, using RDS's. One RDS exemplified comprises 5' sequences from the R. trifolii nifH gene.
    Type: Grant
    Filed: May 10, 1991
    Date of Patent: August 11, 1992
    Assignee: The Lubrizol Corporation
    Inventors: Barry G. Rolfe, John Shine, Kieran F. Scott, John M. Watson, Peter Schofield
  • Patent number: 5053488
    Abstract: Genes and DNA transfer vectors for the expression of human preprorelaxin; sub-units thereof, including genes and transfer vectors for expression of human prorelaxin and the individual A, B and C peptide chains thereof; and equivalents of all such genes. Method for synthesis of the peptides involving recombinant DNA techniques are provided.
    Type: Grant
    Filed: July 6, 1990
    Date of Patent: October 1, 1991
    Assignee: Howard Florey Institute of Experimental Physiology & Medicine
    Inventors: Peter J. Hudson, John Shine, Hugh D. Niall, Geoffrey W. Tregear
  • Patent number: 5008194
    Abstract: The nifH promoter regions of Bradyrhizobium japonicum and Bradyrhizobium sp. (parasponia) have been sequenced and found to be significantly homologous. Recombinant DNA molecules comprising foreign genes under the control of such promoters are provided. Rhizobial species containing such recombinant constructions, either in plasmids or integrated into the genome, are provided. These are especially useful for expressing desired foreign genes within root nodules.
    Type: Grant
    Filed: October 16, 1987
    Date of Patent: April 16, 1991
    Assignee: Lubrizol Genetics, Inc.
    Inventors: Barry G. Rolfe, John Shine, Kieran F. Scott, Hauke Hennecke
  • Patent number: 5001061
    Abstract: The nifD promoter regions of Bradyrhizobium japonicum and Bradyhizobium sp. (Parasponia) have been sequenced and found to be significantly homologous. Recombinant DNA molecules comprising foreign genes under the control of such promoters are provided. Rhizobial species containing such recombinant constructions, either in plasmids or integrated into the genome, are provided. These are especially useful for expressing desired foreign genes within root nodules.
    Type: Grant
    Filed: October 16, 1987
    Date of Patent: March 19, 1991
    Assignee: Lubrizol Genetics, Inc.
    Inventors: Barry G. Rolfe, John Shine, Kieran F. Scott, Hauke Hennecke, Kieran F. Scott
  • Patent number: 4871670
    Abstract: Genes and DNA transfer vectors for the expression of human preprorelaxin; sub-units thereof, including genes and transfer vectors for expression of human prorelaxin and the individual A, B and C peptide chains thereof; and equivalents of all such genes. Methods for synthesis of the peptides involving recombinant DNA techniques.
    Type: Grant
    Filed: May 12, 1986
    Date of Patent: October 3, 1989
    Assignee: Howard Florey Institute of Experimental Physiology and Medicine
    Inventors: Peter J. Hudson, John Shine, Hugh D. Niall, Geoffrey W. Tregear
  • Patent number: 4652525
    Abstract: A recombinant procaryotic microorganism containing the gene coding for insulin.
    Type: Grant
    Filed: June 28, 1983
    Date of Patent: March 24, 1987
    Assignee: The Regents of the University of California
    Inventors: William J. Rutter, Raymond Pictet, John Chirgwin, Howard M. Goodman, Axel Ullrich, John Shine
  • Patent number: 4469631
    Abstract: DNA comprising the naturally occurring nucleotide sequence coding for amino acids 44-90 of .beta.-lipotropin and including the entire coding region for .beta.-endorphin with the exception of the C-terminal glutamine was modified, transferred to an expression transfer vector, and expressed as a fusion protein. The fusion protein was further modified in vitro to yield mature .beta.-endorphin. .beta.-endorphin was purified from a bacterial lysate. The structure and biological activity of the resulting product was proven by immunological assay, and by two independent assays designed to demonstrate biological activity.
    Type: Grant
    Filed: June 10, 1982
    Date of Patent: September 4, 1984
    Assignee: The Regents of the University of California
    Inventors: John D. Baxter, Ivy Fettes, John Shine
  • Patent number: 4447538
    Abstract: A microorganism containing a recombinant DNA transfer vector having the coding sequences for human chorionic somatomammotropin.
    Type: Grant
    Filed: February 5, 1982
    Date of Patent: May 8, 1984
    Assignee: Regents of the University of California
    Inventors: Howard M. Goodman, John Shine, Peter H. Seeburg
  • Patent number: 4440859
    Abstract: Microorganism having a gene derived from a higher organism is produced by isolating cells from a higher organism containing messenger RNA, extracting the messenger RNA, synthesizing a double stranded cDNA using the messenger RNA as a template, inserting the cDNA into a plasmid and transforming a microorganism with the resultant recombinant plasmid.
    Type: Grant
    Filed: September 11, 1981
    Date of Patent: April 3, 1984
    Assignee: The Regents of the University of California
    Inventors: William J. Rutter, Howard M. Goodman, Axel Ullrich, John Shine, John Chirgwin, Raymond Pictet
  • Patent number: 4407948
    Abstract: A method for purifying a DNA fragment of specific desired nucleotide sequence containing a restriction site, from a population of DNA molecules homogeneous in length by endonuclease cleavage and fractionation.
    Type: Grant
    Filed: February 5, 1982
    Date of Patent: October 4, 1983
    Assignee: The Regents of the University of California
    Inventors: Howard M. Goodman, John Shine, Peter H. Seeburg
  • Patent number: 4363877
    Abstract: Recombinant DNA transfer vectors containing codons for human somatomammotropin and for human growth hormone.
    Type: Grant
    Filed: April 19, 1978
    Date of Patent: December 14, 1982
    Assignee: The Regents of the University of California
    Inventors: Howard M. Goodman, John Shine, Peter H. Seeburg
  • Patent number: 4350764
    Abstract: DNA comprising the naturally occurring nucleotide sequence coding for amino acids 44-90 of .beta.-lipotropin and including the entire coding region for .beta.-endorphin with the exception of the C-terminal glutamine was modified, transferred to an expression transfer vector, and expressed as a fusion protein. The fusion protein was further modified in vitro to yield mature .beta.-endorphin. .beta.-endorphin was purified from a bacterial lysate. The structure and biological activity of the resulting product was proven by immunological assay, and by two independent assays designed to demonstrate biological activity.
    Type: Grant
    Filed: March 10, 1980
    Date of Patent: September 21, 1982
    Assignee: The Regents of the University of California
    Inventors: John D. Baxter, Ivy Fettes, John Shine
  • Patent number: 4322499
    Abstract: A technique suitable for cloning a cDNA having a base sequence coding for the ACTH/LPH precursor is disclosed. The invention is exemplified by the cloning of a cDNA fragment comprising a base sequence coding for the endorphin region. The fragment, hereinafter termed the endorphin gene cDNA sequence, was obtained from cultured mouse pituitary tumor cells known to produce the ACTH/LPH precursor protein.
    Type: Grant
    Filed: December 22, 1978
    Date of Patent: March 30, 1982
    Assignee: The Regents of the University of California
    Inventors: John D. Baxter, James L. Roberts, Peter H. Seeburg, Howard M. Goodman, John Shine